SUMMARY We retrospectively studied the postoperative results in nine patients with corneal scarring due to herpes zoster ophthalmicus who underwent penetrating keratoplasty. This was a highly selected group that satisfied all of the following criteria: (a) absence of active disease of the ocular surface and eyelids, (b) intraocular pressure under control, and (c) absence of active keratouveitis. Penetrating keratoplasty after herpes zoster ophthalmicus may do well in patients with long preoperative quiescent periods in whom these restrictive preoperative criteria are observed.
for one case that was lost to follow-up three months postoperatively. The patients ranged in age from 55 to 86 years (mean age 70) at the time of PKP. Six patients were female and three were male. Postoperative follow-up time ranged from 5 to 40 (mean 18) months. The diagnosis of herpes zoster keratopathy was based on the presence of antecedent skin vesicles and scarring in the ophthalmic division of the trigeminal nerve dermatome. All affected eyes had corneal stromal scarring with central involvement. Each PKP was performed on a previously ungrafted eye.
Preoperatively one patient (case 9) had mild Fuchs's corneal dystrophy and macular oedema in the affected eye. In this patient the main cause of poor vision was the severe corneal scarring due to HZO and not the mild Fuchs's dystrophy. Two patients (cases 6 At each daily postoperative slit-lamp examination the epithelium on the graft was assessed with topical fluorescein and checked for defects. Postoperative rises in intraocular pressure were treated with timolol, dipivefrin, and/or acetazolamide. The patients were examined daily for up to five postoperative days until discharge from the hospital, then at one week, three weeks, and at progressively longer intervals. The diagnosis of corneal graft rejection was based on the presence in the donor cornea of keratic precipitates, endothelial rejection lines, or subepithelial infiltrates. The presence of iritis and increased graft thickness constituted an additional, but not necessary, criterion for immune rejection. Graft failure was defined as an irreversibly thick and oedematous, or a scarred and opaque, donor cornea.
Results
Seven of the nine patients had a clear graft at the end of the follow-up period ranging from 5 to 40 (mean 18) months. Six of the patients with clear grafts had a final visual acuity of 20/50 or better. However, one patient with a clear graft (case 7) had a final visual acuity of counting fingers at 2 feet (60 cm) due to macular degeneration with subretinal neovascularisation. Table 1 summarises the clinical findings.
To study the significance of the preoperative quiescent period on the prognosis of the grafts we Preoperative corneal vascularisation was present in six of nine patients and was not correlated with postoperative immune graft rejection. Of these six cases three had superficial corneal vessels (cases 1, 2, and 9) and three had stromal vessels (cases 4, 6, and 7). Of the two patients who had graft rejection one (case 9) had some superficial peripheral vessels preoperatively, while the other (case 8) 
